During TIDES: Europe 2018, meet our experts to learn more about oligonucleotide characterisation - 6-9 November 2018, Amsterdam, Netherlands
Intertek will present at TIDES: Europe 2018 on analytical development strategies which help to accelerate oligonucleotide product development from early characterisation to late-stage development & commercialization. meet our team at Booth 37.
Presentation Download: Oligonucleotide Characterisation by NMR and Consideration of Orthogonal Techniques
Expert: Thomas Brown, Senior Analyst (Oligonucleotide Services), Intertek Pharmaceutical Services
An overview of NMR techniques for Oligonucleotide analysis, including a discussion on how NMR can be used in place of more conventional techniques for melting temperature calculation, the challenges presented by NMR and a reflection on regulatory aspects. Email firstname.lastname@example.org to request a copy of the presentation.
With a growing global development pipeline of oligonucleotide therapeutics to treat a variety of disease targets, overcoming the challenges of innovation, regulatory authorization, production and the inherent complexity of oligos is critical to success. Contact our experts in oligonucleotide analysis and bioanalysis, to discuss our regulatory-driven, phase-appropriate characterization and biophysical analysis in support of CMC programs which GMP and CMC laboratory services, pharmaceutical analysis, quality control analysis, elemental impurities, extractables and leachables, stability programs, inhalation drug development, method development and method validation will be available to review your challenges and discuss and how our unrivalled expertise can help you to accelerate the development timelines.
Need help or have a question?